Genea Biomedx and PRP Diagnostic Imaging. He was head of Asia for Macquarie Capital and global head of investment banking for the international arm of China’s largest securities firm, CITIC Securities ...
LH received speaker and consultancy fees from BiomeDx, BMS, Immunocore, Kyowa Kirin, Merck, MSD, Myoncare, Novartis, Pieris, Pierre-Fabre, Roche, Sanofi, Stemline Therapeutics, SUN and Therakos. The ...
Background: Multiple myeloma (MM) remains an essentially incurable disease. This study aimed to establish a predictive model for estimating prognosis in newly diagnosed MM based on gene expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback